Texas Instruments

TXN · NASDAQ

$277.78+$1.63 (+0.59%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $276.15

TXN analyst rating

HoldConsensus of 24 analysts over the last 12 months. 54% rate it a buy.

Strong buy0
Buy13
Hold9
Underperform1
Sell1

12-month price target · 35 analysts

Average $315.72 (+13.7% upside)

Low: $186.44
Now: $277.78
High: $420.00

Upgrades and downgrades

The latest rating actions, newest first

TXN analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wells Fargo	Oct 20, 2026	Maintains	Equal-Weight	$310.00 → $300.00	54%
TD Cowen	Oct 19, 2026	Maintains	Buy	$340.00 → $330.00	39%
Cantor Fitzgerald	Aug 17, 2026	Maintains	Neutral	$340.00	77%
Rosenblatt	Jul 24, 2026	Maintains	Buy	$330.00 → $350.00	53%
Bernstein	Jul 23, 2026	Maintains	Market Perform	$250.00 → $290.00	65%
JP Morgan	Jul 23, 2026	Maintains	Overweight	$280.00 → $340.00	67%
Morgan Stanley	Jul 23, 2026	Maintains	Underweight	$230.00 → $255.00	56%
TD Cowen	Jul 23, 2026	Maintains	Buy	$360.00 → $340.00	39%
Truist Securities	Jul 23, 2026	Maintains	Hold	$278.00 → $300.00	75%
Mizuho	Jul 23, 2026	Maintains	Neutral	$300.00 → $305.00	59%

The case for and against

Updated Oct 14, 2026

Bull case

Texas Instruments is well positioned because broadening demand in Industrial, Automotive, and Data Center is translating into faster revenue growth, stronger backlog, and a more durable recovery than a simple restocking cycle. In 2QF26, sales reached $5.46B, up 23% Y/Y, while gross margin expanded to 61.4% and GAAP EPS rose 52% Y/Y to $2.14, showing meaningful operating leverage as wafer loadings and 300mm mix improve cost efficiency. Its manufacturing footprint, roughly 30-week lead times versus competitors near 52 weeks, and $7.0B of cash and short-term investments support supply reliability, margin expansion, and continued free-cash-flow generation as end-market growth persists.

Bear case

Texas Instruments is facing a weak fundamental setup because market share loss in its Analog and Embedded businesses, which generate roughly 90% of revenue, threatens the company’s core earnings engine even as those segments remain central to its industrial franchise. A longer-than-expected semiconductor recovery could delay revenue normalization, and despite 2Q26 revenue of $5.463B and EPS of $2.14 beating estimates, the market’s initial stock weakness highlights skepticism that improving backlog, pricing, and factory loadings will translate into durable growth. Macro risks, including slower manufacturing activity in the US, EU, and China, plus potential end-demand weakness and management execution risk, further support a negative outlook on Texas Instruments.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.